Mary Lynne Hedley is Director at Centessa Pharmaceuticals plc (CNTA). SEC records also connect Hedley to VEEVA SYSTEMS INC (VEEV) and ELI LILLY & Co (LLY). Hedley has reported 16 insider filings with the SEC since 2024. The most recent filing was in June 2026.
Every role Mary Lynne Hedley has reported on a Form 4, reconstructed from the filings themselves. Reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
Centessa Pharmaceuticals plc (CNTA)1 filingVEEVA SYSTEMS INC (VEEV)2 filingsUpdated Aug 30, 2026
Mary Lynne Hedley is Director of Centessa Pharmaceuticals plc (CNTA). 16 SEC Form 4 filings on record going back to 2024, most recently on 24 June 2026.
Every recent SEC Form 4 transaction Mary Lynne Hedley has reported, most recent first.
InsiderAlpha's records for Mary Lynne Hedley go back to 2024: 16 primary Form 4 filings, an average of 5.3 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Insiders who reported open-market trades in the last 12 months at the companies Mary Lynne Hedley files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Mary Lynne Hedley is a corporate insider, tracked as Director of Centessa Pharmaceuticals plc (CNTA). InsiderAlpha holds 16 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
3 primary Form 4 filings in the last 90 days, covering 2 companies.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
$LLY ELI LILLY & Co9 shares @ $1,062.19$10K